It is difficult to explain this discrepancy, however, it should be noted that the elevation of circulating OPG levels and the decreased RANKL levels could represent a compensatory mechanism to limit the liver damage during the progress of NAFLD to fibrosis. This evidence concerns the gene TNFSF11 and metabolic dysfunction-associated steatotic liver disease.